XL147 News
Most Popular XL147 Story
Exelixis' $140M upfront caps biotech deal blitz
Exelixis announced this morning that it will license a pair of early-stage cancer drugs to Sanofi-Aventis in a pact that's worth $140 million upfront and could eventually break the billion-dollar Read more...
Latest Headlines
- May 28, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
